Eckert & Ziegler Strahlen und Medizintechnik AG represents strong values and a clear corporate philosophy. This German company operates in the field of radiation therapy and medical technology, aiming to improve the quality of life for patients worldwide. Their core values include innovation, excellence, and sustainability. Eckert & Ziegler Strahlen und Medizintechnik AG fosters a culture of continuous improvement and invests in research and development to offer cutting-edge solutions. By prioritizing patient well-being, the company ensures the highest standards of quality and safety in their products and services. With a commitment to social and environmental responsibility, Eckert & Ziegler Strahlen und Medizintechnik AG strives to make a positive impact while delivering value to stakeholders.

Eckert & Ziegler Strahlen und Medizintechnik AG is primarily present in various countries and regions across the globe. With a strong international presence, the company operates in several key markets including Germany, the United States, France, Brazil, and Japan, among others. Its business activities span across Europe, North and South America, Asia, and other parts of the world. The global reach of Eckert & Ziegler Strahlen und Medizintechnik AG enables the company to cater to a diverse customer base, while continuously expanding its market share and leveraging its expertise in radiation and medical technology.

Eckert & Ziegler Strahlen und Medizintechnik AG, a renowned stock company in the medical technology sector, has achieved significant milestones over the years. The company has demonstrated its commitment to innovation and growth, establishing itself as a global leader. Notable achievements include the development of groundbreaking radiation therapy solutions, strategic partnerships with leading medical institutions, and consistent revenue growth. Eckert & Ziegler Strahlen und Medizintechnik AG's dedication to quality and cutting-edge advancements has earned them a strong reputation within the industry. These accomplishments solidify the company's position as a key player in the healthcare sector, driving further success and shareholder value.

Eckert & Ziegler Strahlen und Medizintechnik AG is a renowned company with a rich history and background. Founded in Berlin, Germany in 1992, the company specializes in radiation therapy, isotope technology, and medical imaging. Eckert & Ziegler has become a global leader in the field, providing innovative solutions for the diagnosis and treatment of cancer and other diseases. With a strong focus on research and development, the company has continuously expanded its product portfolio and established a solid reputation for delivering high-quality and reliable medical technology. Eckert & Ziegler's commitment to excellence and dedication to improving healthcare has enabled it to become a trusted name in the industry.

The main competitors of Eckert & Ziegler Strahlen und Medizintechnik AG in the market include companies like Varian Medical Systems, Elekta AB, and IBA Molecular.

Eckert & Ziegler Strahlen und Medizintechnik AG is primarily active in the radiation therapy and nuclear medicine industries.

The business model of Eckert & Ziegler Strahlen und Medizintechnik AG focuses on radiation technology and medical equipment. As a leading global provider, the company specializes in the development, production, and distribution of isotope technology, radiation therapy equipment, and radiopharmaceuticals. Eckert & Ziegler operates in various segments, including Isotope Products, Radiopharma, Treatment and Services, and Environmental Services. With a strong emphasis on innovation and quality, the company strives to meet the needs of medical professionals and improve patient care worldwide. Eckert & Ziegler's comprehensive range of products and services caters to the growing demand in the medical and industrial sectors.

KGV-d ei saa praegu Eckert & Ziegler jaoks arvutada.

KUV-d ei ole võimalik hetkel Eckert & Ziegler jaoks arvutada.

AlleAktien kvaliteediskoor ettevõttele Eckert & Ziegler on 7/10.

Praegu ei saa Eckert & Ziegler käivet arvutada.

Praegu ei ole võimalik kasumit Eckert & Ziegler jaoks arvutada.

The Eckert & Ziegler Strahlen und Medizintechnik AG is a globally operating provider of high-quality products and services in the field of radiation and medical technology. The company was founded in 1997 and is headquartered in Berlin. The business model of Eckert & Ziegler Strahlen und Medizintechnik AG is based on three main divisions: radiation therapy, isotope applications, and radiopharmaceuticals. Each division is focused on products and services specifically developed for its respective area. The radiation therapy division offers solutions for cancer treatment, including radioactive implants that are specifically inserted into the tumor, as well as radioactive sources for radiation devices. These measures can be used in both brachytherapy and teletherapy. Isotope applications include the development, production, and sale of isotopes for diagnostics and treatment of diseases. This includes radioactive markers for PET scanners, as well as radioactive capsules for thyroid treatment. The radiopharmaceutical division is another important pillar of the business model. Special medications containing radioactive substances are used to target specific areas of the body. Radiopharmaceuticals are primarily used in diagnostics and cancer treatment. In addition to the three main divisions, Eckert & Ziegler Strahlen und Medizintechnik AG also operates an extensive service and maintenance program for its products. This includes calibration of measuring devices, as well as commissioning and maintenance of radiation devices. The products of Eckert & Ziegler Strahlen und Medizintechnik AG are used worldwide in hospitals, research institutions, and the industry. The constant development of products and services is an important element of the business model. In summary, the business model of Eckert & Ziegler Strahlen und Medizintechnik AG is based on high-quality solutions in the field of radiation and medical technology. With its three main divisions and the service and maintenance program, the company offers a wide range of products and services that are used worldwide. The constant development of products and services, as well as a high customer orientation, are important success factors for the company.

Eckert & Ziegler maksab dividendi 0 EUR, mis jaotatakse 1 väljamakse peale aasta jooksul.

Eckert & Ziegler maksab aastas 1 korda dividendi.

Eckert & Ziegler ISIN on DE0005659700.

Eckert & Ziegler WKN on 565970.

Eckert & Ziegler tähis on EUZ.DE.

Viimase 12 kuu jooksul maksis Eckert & Ziegler dividendi suuruses . See vastab ligikaudu dividenditootlusele. Järgneva 12 kuu jooksul maksab Eckert & Ziegler tõenäoliselt dividendi summas 0,55 EUR.

Eckert & Ziegler praegune dividenditootlus on .

Eckert & Ziegler maksab kvartaalset dividendi. See makstakse välja kuudel juuli, juuli, juuni, juuli.

Eckert & Ziegler maksis viimase 23 aasta jooksul igal aastal dividendi.

Järgmise 12 kuu jooksul oodatakse dividende summas 0,55 EUR. See vastab dividenditootlusele 1,22 %.

Eckert & Ziegler on liigitatud sektorisse 'Tervis'.

Viimase Eckert & Ziegler dividendide saamiseks 1.7.2024 suuruses 0,05 EUR pidid sul olema aktsiaid portfellis enne eks-dividendi päeva 27.6.2024.

Viimane dividendimakse toimus 1.7.2024.

Aastal 2023 maksis Eckert & Ziegler 0,5 EUR dividende.

Eckert & Ziegler dividendid makstakse välja EUR.